结直肠癌中的微生物群与肝脏转移有关
Peijun Wei1,2,3, Weiming Han1,2,3, Zitong Zhang1,2,3
1Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangzhou 510060, China.
概括
肠道细菌,包括Fusobacterium nucleatum,显著影响结直肠癌 (CRC) 的进展和肝转移 (CRLM). 了解这种肠道菌群联系为CRLM提供了新的治疗和预防策略.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 结肠直肠癌 (CRC) 的患病率正在上升,转移,特别是到肝脏 (CRLM),是死亡的主要原因.
- 肠道微生物群,包括像Fusobacterium nucleatum,Escherichia coli和Bacteroides fragilis这样的特定细菌,都与CRC的发展有关.
- 现有的研究强调了肠道微生物群在CRC中的作用,但将其与CRLM联系在一起的具体机制不太了解.
研究的目的:
- 总结目前对肠道微生物群和结直肠癌肝转移 (CRLM) 之间的相互作用的理解.
- 讨论肠道菌群在CRLM治疗策略中的重要性.
- 为了解CRLM机制和基于微生物组的疗法提出新的方法.
主要方法:
- 文献综述和综合关于肠道微生物群和CRLM的现有研究.
- 对调查转移部位细菌存在的研究进行分析.
- 检查微生物产品及其对CRC进展的影响.
主要成果:
- 在遥远的CRC转移中检测到可活的Fusobacterium nucleatum.
- 肠道微生物群产品 (例如,脂多糖,甲酸盐) 影响CRC的发展.
- 肠道微生物群和CRLM之间存在强烈的相互作用,影响其发病和进展.
结论:
- 肠道微生物群在结直肠癌肝脏转移的发展和进展中发挥着至关重要的作用.
- 准肠道微生物组为CRLM治疗和预防提供了一个有希望的途径.
- 对肠道微生物群-CRLM轴的进一步研究可以导致创新的治疗策略.
相关概念视频
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Microbiota of the Large Intestine
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


